Global Spinal Muscular Atrophy Medicine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Spinal Muscular Atrophy Medicine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Spinal Muscular Atrophy Medicine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Spinal Muscular Atrophy Medicine by Country/Region, 2017, 2022 & 2028

2.2 Spinal Muscular Atrophy Medicine Segment by Type

2.2.1 LMI-070

2.2.2 ND-602

2.2.3 NT-1654

2.2.4 Nusinersen

2.2.5 NXD-30001

2.2.6 Others

2.3 Spinal Muscular Atrophy Medicine Sales by Type

2.3.1 Global Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022)

2.3.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Spinal Muscular Atrophy Medicine Sale Price by Type (2017-2022)

2.4 Spinal Muscular Atrophy Medicine Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Spinal Muscular Atrophy Medicine Sales by Application

2.5.1 Global Spinal Muscular Atrophy Medicine Sale Market Share by Application (2017-2022)

2.5.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Spinal Muscular Atrophy Medicine Sale Price by Application (2017-2022)

3 Global Spinal Muscular Atrophy Medicine by Company

3.1 Global Spinal Muscular Atrophy Medicine Breakdown Data by Company

3.1.1 Global Spinal Muscular Atrophy Medicine Annual Sales by Company (2020-2022)

3.1.2 Global Spinal Muscular Atrophy Medicine Sales Market Share by Company (2020-2022)

3.2 Global Spinal Muscular Atrophy Medicine Annual Revenue by Company (2020-2022)

3.2.1 Global Spinal Muscular Atrophy Medicine Revenue by Company (2020-2022)

3.2.2 Global Spinal Muscular Atrophy Medicine Revenue Market Share by Company (2020-2022)

3.3 Global Spinal Muscular Atrophy Medicine Sale Price by Company

3.4 Key Manufacturers Spinal Muscular Atrophy Medicine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Spinal Muscular Atrophy Medicine Product Location Distribution

3.4.2 Players Spinal Muscular Atrophy Medicine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Spinal Muscular Atrophy Medicine by Geographic Region

4.1 World Historic Spinal Muscular Atrophy Medicine Market Size by Geographic Region (2017-2022)

4.1.1 Global Spinal Muscular Atrophy Medicine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Spinal Muscular Atrophy Medicine Annual Revenue by Geographic Region

4.2 World Historic Spinal Muscular Atrophy Medicine Market Size by Country/Region (2017-2022)

4.2.1 Global Spinal Muscular Atrophy Medicine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Spinal Muscular Atrophy Medicine Annual Revenue by Country/Region

4.3 Americas Spinal Muscular Atrophy Medicine Sales Growth

4.4 APAC Spinal Muscular Atrophy Medicine Sales Growth

4.5 Europe Spinal Muscular Atrophy Medicine Sales Growth

4.6 Middle East & Africa Spinal Muscular Atrophy Medicine Sales Growth

5 Americas

5.1 Americas Spinal Muscular Atrophy Medicine Sales by Country

5.1.1 Americas Spinal Muscular Atrophy Medicine Sales by Country (2017-2022)

5.1.2 Americas Spinal Muscular Atrophy Medicine Revenue by Country (2017-2022)

5.2 Americas Spinal Muscular Atrophy Medicine Sales by Type

5.3 Americas Spinal Muscular Atrophy Medicine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Spinal Muscular Atrophy Medicine Sales by Region

6.1.1 APAC Spinal Muscular Atrophy Medicine Sales by Region (2017-2022)

6.1.2 APAC Spinal Muscular Atrophy Medicine Revenue by Region (2017-2022)

6.2 APAC Spinal Muscular Atrophy Medicine Sales by Type

6.3 APAC Spinal Muscular Atrophy Medicine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Spinal Muscular Atrophy Medicine by Country

7.1.1 Europe Spinal Muscular Atrophy Medicine Sales by Country (2017-2022)

7.1.2 Europe Spinal Muscular Atrophy Medicine Revenue by Country (2017-2022)

7.2 Europe Spinal Muscular Atrophy Medicine Sales by Type

7.3 Europe Spinal Muscular Atrophy Medicine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Spinal Muscular Atrophy Medicine by Country

8.1.1 Middle East & Africa Spinal Muscular Atrophy Medicine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Spinal Muscular Atrophy Medicine Revenue by Country (2017-2022)

8.2 Middle East & Africa Spinal Muscular Atrophy Medicine Sales by Type

8.3 Middle East & Africa Spinal Muscular Atrophy Medicine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Spinal Muscular Atrophy Medicine

10.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine

10.4 Industry Chain Structure of Spinal Muscular Atrophy Medicine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Spinal Muscular Atrophy Medicine Distributors

11.3 Spinal Muscular Atrophy Medicine Customer

12 World Forecast Review for Spinal Muscular Atrophy Medicine by Geographic Region

12.1 Global Spinal Muscular Atrophy Medicine Market Size Forecast by Region

12.1.1 Global Spinal Muscular Atrophy Medicine Forecast by Region (2023-2028)

12.1.2 Global Spinal Muscular Atrophy Medicine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Spinal Muscular Atrophy Medicine Forecast by Type

12.7 Global Spinal Muscular Atrophy Medicine Forecast by Application

13 Key Players Analysis

13.1 Astellas Pharma Inc.

13.1.1 Astellas Pharma Inc. Company Information

13.1.2 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Offered

13.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Astellas Pharma Inc. Main Business Overview

13.1.5 Astellas Pharma Inc. Latest Developments

13.2 AveXis, Inc.

13.2.1 AveXis, Inc. Company Information

13.2.2 AveXis, Inc. Spinal Muscular Atrophy Medicine Product Offered

13.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AveXis, Inc. Main Business Overview

13.2.5 AveXis, Inc. Latest Developments

13.3 Bioblast Pharma Ltd.

13.3.1 Bioblast Pharma Ltd. Company Information

13.3.2 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Offered

13.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bioblast Pharma Ltd. Main Business Overview

13.3.5 Bioblast Pharma Ltd. Latest Developments

13.4 Cytokinetics, Inc. 24

13.4.1 Cytokinetics, Inc. 24 Company Information

13.4.2 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Product Offered

13.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cytokinetics, Inc. 24 Main Business Overview

13.4.5 Cytokinetics, Inc. 24 Latest Developments

13.5 F. Hoffmann-La Roche Ltd.

13.5.1 F. Hoffmann-La Roche Ltd. Company Information

13.5.2 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Product Offered

13.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.6 Genethon

13.6.1 Genethon Company Information

13.6.2 Genethon Spinal Muscular Atrophy Medicine Product Offered

13.6.3 Genethon Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Genethon Main Business Overview

13.6.5 Genethon Latest Developments

13.7 Genzyme Corporation

13.7.1 Genzyme Corporation Company Information

13.7.2 Genzyme Corporation Spinal Muscular Atrophy Medicine Product Offered

13.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Genzyme Corporation Main Business Overview

13.7.5 Genzyme Corporation Latest Developments

13.8 GMP-Orphan SAS

13.8.1 GMP-Orphan SAS Company Information

13.8.2 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product Offered

13.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GMP-Orphan SAS Main Business Overview

13.8.5 GMP-Orphan SAS Latest Developments

13.9 Ionis Pharmaceuticals, Inc.

13.9.1 Ionis Pharmaceuticals, Inc. Company Information

13.9.2 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Product Offered

13.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Ionis Pharmaceuticals, Inc. Main Business Overview

13.9.5 Ionis Pharmaceuticals, Inc. Latest Developments

13.10 Longevity Biotech, Inc

13.10.1 Longevity Biotech, Inc Company Information

13.10.2 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product Offered

13.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Longevity Biotech, Inc Main Business Overview

13.10.5 Longevity Biotech, Inc Latest Developments

13.11 Neurodyn Inc.

13.11.1 Neurodyn Inc. Company Information

13.11.2 Neurodyn Inc. Spinal Muscular Atrophy Medicine Product Offered

13.11.3 Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Neurodyn Inc. Main Business Overview

13.11.5 Neurodyn Inc. Latest Developments

13.12 Neurotune AG

13.12.1 Neurotune AG Company Information

13.12.2 Neurotune AG Spinal Muscular Atrophy Medicine Product Offered

13.12.3 Neurotune AG Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Neurotune AG Main Business Overview

13.12.5 Neurotune AG Latest Developments

13.13 Novartis AG

13.13.1 Novartis AG Company Information

13.13.2 Novartis AG Spinal Muscular Atrophy Medicine Product Offered

13.13.3 Novartis AG Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Novartis AG Main Business Overview

13.13.5 Novartis AG Latest Developments

13.14 Sarepta Therapeutics, Inc.

13.14.1 Sarepta Therapeutics, Inc. Company Information

13.14.2 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product Offered

13.14.3 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Sarepta Therapeutics, Inc. Main Business Overview

13.14.5 Sarepta Therapeutics, Inc. Latest Developments

13.15 Voyager Therapeutics, Inc.

13.15.1 Voyager Therapeutics, Inc. Company Information

13.15.2 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product Offered

13.15.3 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Voyager Therapeutics, Inc. Main Business Overview

13.15.5 Voyager Therapeutics, Inc. Latest Developments

13.16 Vybion, Inc.

13.16.1 Vybion, Inc. Company Information

13.16.2 Vybion, Inc. Spinal Muscular Atrophy Medicine Product Offered

13.16.3 Vybion, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Vybion, Inc. Main Business Overview

13.16.5 Vybion, Inc. Latest Developments

13.17 WAVE Life Sciences Ltd.

13.17.1 WAVE Life Sciences Ltd. Company Information

13.17.2 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Product Offered

13.17.3 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 WAVE Life Sciences Ltd. Main Business Overview

13.17.5 WAVE Life Sciences Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Spinal Muscular Atrophy Medicine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Spinal Muscular Atrophy Medicine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of LMI-070

Table 4. Major Players of ND-602

Table 5. Major Players of NT-1654

Table 6. Major Players of Nusinersen

Table 7. Major Players of NXD-30001

Table 8. Major Players of Others

Table 9. Global Spinal Muscular Atrophy Medicine Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022)

Table 11. Global Spinal Muscular Atrophy Medicine Revenue by Type (2017-2022) & ($ million)

Table 12. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type (2017-2022)

Table 13. Global Spinal Muscular Atrophy Medicine Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Spinal Muscular Atrophy Medicine Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Spinal Muscular Atrophy Medicine Sales Market Share by Application (2017-2022)

Table 16. Global Spinal Muscular Atrophy Medicine Revenue by Application (2017-2022)

Table 17. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Application (2017-2022)

Table 18. Global Spinal Muscular Atrophy Medicine Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Spinal Muscular Atrophy Medicine Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Spinal Muscular Atrophy Medicine Sales Market Share by Company (2020-2022)

Table 21. Global Spinal Muscular Atrophy Medicine Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Company (2020-2022)

Table 23. Global Spinal Muscular Atrophy Medicine Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Spinal Muscular Atrophy Medicine Producing Area Distribution and Sales Area

Table 25. Players Spinal Muscular Atrophy Medicine Products Offered

Table 26. Spinal Muscular Atrophy Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Spinal Muscular Atrophy Medicine Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Spinal Muscular Atrophy Medicine Sales Market Share Geographic Region (2017-2022)

Table 31. Global Spinal Muscular Atrophy Medicine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Spinal Muscular Atrophy Medicine Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Spinal Muscular Atrophy Medicine Sales Market Share by Country/Region (2017-2022)

Table 35. Global Spinal Muscular Atrophy Medicine Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Spinal Muscular Atrophy Medicine Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Spinal Muscular Atrophy Medicine Sales Market Share by Country (2017-2022)

Table 39. Americas Spinal Muscular Atrophy Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2017-2022)

Table 41. Americas Spinal Muscular Atrophy Medicine Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022)

Table 43. Americas Spinal Muscular Atrophy Medicine Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Spinal Muscular Atrophy Medicine Sales Market Share by Application (2017-2022)

Table 45. APAC Spinal Muscular Atrophy Medicine Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Spinal Muscular Atrophy Medicine Sales Market Share by Region (2017-2022)

Table 47. APAC Spinal Muscular Atrophy Medicine Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2017-2022)

Table 49. APAC Spinal Muscular Atrophy Medicine Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022)

Table 51. APAC Spinal Muscular Atrophy Medicine Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Spinal Muscular Atrophy Medicine Sales Market Share by Application (2017-2022)

Table 53. Europe Spinal Muscular Atrophy Medicine Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Country (2017-2022)

Table 55. Europe Spinal Muscular Atrophy Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2017-2022)

Table 57. Europe Spinal Muscular Atrophy Medicine Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022)

Table 59. Europe Spinal Muscular Atrophy Medicine Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Spinal Muscular Atrophy Medicine Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Spinal Muscular Atrophy Medicine Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Spinal Muscular Atrophy Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Spinal Muscular Atrophy Medicine Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Spinal Muscular Atrophy Medicine Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Spinal Muscular Atrophy Medicine Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Spinal Muscular Atrophy Medicine

Table 70. Key Market Challenges & Risks of Spinal Muscular Atrophy Medicine

Table 71. Key Industry Trends of Spinal Muscular Atrophy Medicine

Table 72. Spinal Muscular Atrophy Medicine Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Spinal Muscular Atrophy Medicine Distributors List

Table 75. Spinal Muscular Atrophy Medicine Customer List

Table 76. Global Spinal Muscular Atrophy Medicine Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Spinal Muscular Atrophy Medicine Sales Market Forecast by Region

Table 78. Global Spinal Muscular Atrophy Medicine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Spinal Muscular Atrophy Medicine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Spinal Muscular Atrophy Medicine Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Spinal Muscular Atrophy Medicine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Spinal Muscular Atrophy Medicine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Spinal Muscular Atrophy Medicine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Spinal Muscular Atrophy Medicine Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Spinal Muscular Atrophy Medicine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Spinal Muscular Atrophy Medicine Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Spinal Muscular Atrophy Medicine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Application (2023-2028)

Table 96. Astellas Pharma Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 97. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 98. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Astellas Pharma Inc. Main Business

Table 100. Astellas Pharma Inc. Latest Developments

Table 101. AveXis, Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 102. AveXis, Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 103. AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. AveXis, Inc. Main Business

Table 105. AveXis, Inc. Latest Developments

Table 106. Bioblast Pharma Ltd. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 107. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Offered

Table 108. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Bioblast Pharma Ltd. Main Business

Table 110. Bioblast Pharma Ltd. Latest Developments

Table 111. Cytokinetics, Inc. 24 Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 112. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Product Offered

Table 113. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Cytokinetics, Inc. 24 Main Business

Table 115. Cytokinetics, Inc. 24 Latest Developments

Table 116. F. Hoffmann-La Roche Ltd. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 117. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Product Offered

Table 118. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. F. Hoffmann-La Roche Ltd. Main Business

Table 120. F. Hoffmann-La Roche Ltd. Latest Developments

Table 121. Genethon Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 122. Genethon Spinal Muscular Atrophy Medicine Product Offered

Table 123. Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Genethon Main Business

Table 125. Genethon Latest Developments

Table 126. Genzyme Corporation Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 127. Genzyme Corporation Spinal Muscular Atrophy Medicine Product Offered

Table 128. Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Genzyme Corporation Main Business

Table 130. Genzyme Corporation Latest Developments

Table 131. GMP-Orphan SAS Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 132. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product Offered

Table 133. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. GMP-Orphan SAS Main Business

Table 135. GMP-Orphan SAS Latest Developments

Table 136. Ionis Pharmaceuticals, Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 137. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 138. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Ionis Pharmaceuticals, Inc. Main Business

Table 140. Ionis Pharmaceuticals, Inc. Latest Developments

Table 141. Longevity Biotech, Inc Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 142. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product Offered

Table 143. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Longevity Biotech, Inc Main Business

Table 145. Longevity Biotech, Inc Latest Developments

Table 146. Neurodyn Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 147. Neurodyn Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 148. Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. Neurodyn Inc. Main Business

Table 150. Neurodyn Inc. Latest Developments

Table 151. Neurotune AG Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 152. Neurotune AG Spinal Muscular Atrophy Medicine Product Offered

Table 153. Neurotune AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. Neurotune AG Main Business

Table 155. Neurotune AG Latest Developments

Table 156. Novartis AG Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 157. Novartis AG Spinal Muscular Atrophy Medicine Product Offered

Table 158. Novartis AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 159. Novartis AG Main Business

Table 160. Novartis AG Latest Developments

Table 161. Sarepta Therapeutics, Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 162. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 163. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 164. Sarepta Therapeutics, Inc. Main Business

Table 165. Sarepta Therapeutics, Inc. Latest Developments

Table 166. Voyager Therapeutics, Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 167. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 168. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 169. Voyager Therapeutics, Inc. Main Business

Table 170. Voyager Therapeutics, Inc. Latest Developments

Table 171. Vybion, Inc. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 172. Vybion, Inc. Spinal Muscular Atrophy Medicine Product Offered

Table 173. Vybion, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 174. Vybion, Inc. Main Business

Table 175. Vybion, Inc. Latest Developments

Table 176. WAVE Life Sciences Ltd. Basic Information, Spinal Muscular Atrophy Medicine Manufacturing Base, Sales Area and Its Competitors

Table 177. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Product Offered

Table 178. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 179. WAVE Life Sciences Ltd. Main Business

Table 180. WAVE Life Sciences Ltd. Latest Developments

List of Figures

Figure 1. Picture of Spinal Muscular Atrophy Medicine

Figure 2. Spinal Muscular Atrophy Medicine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Spinal Muscular Atrophy Medicine Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Spinal Muscular Atrophy Medicine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Spinal Muscular Atrophy Medicine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of LMI-070

Figure 10. Product Picture of ND-602

Figure 11. Product Picture of NT-1654

Figure 12. Product Picture of Nusinersen

Figure 13. Product Picture of NXD-30001

Figure 14. Product Picture of Others

Figure 15. Global Spinal Muscular Atrophy Medicine Sales Market Share by Type in 2021

Figure 16. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type (2017-2022)

Figure 17. Spinal Muscular Atrophy Medicine Consumed in Hospital

Figure 18. Global Spinal Muscular Atrophy Medicine Market: Hospital (2017-2022) & (K Pcs)

Figure 19. Spinal Muscular Atrophy Medicine Consumed in Clinic

Figure 20. Global Spinal Muscular Atrophy Medicine Market: Clinic (2017-2022) & (K Pcs)

Figure 21. Spinal Muscular Atrophy Medicine Consumed in Others

Figure 22. Global Spinal Muscular Atrophy Medicine Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Spinal Muscular Atrophy Medicine Sales Market Share by Application (2017-2022)

Figure 24. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Application in 2021

Figure 25. Spinal Muscular Atrophy Medicine Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Company in 2021

Figure 27. Global Spinal Muscular Atrophy Medicine Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Geographic Region in 2021

Figure 29. Global Spinal Muscular Atrophy Medicine Sales Market Share by Region (2017-2022)

Figure 30. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Country/Region in 2021

Figure 31. Americas Spinal Muscular Atrophy Medicine Sales 2017-2022 (K Pcs)

Figure 32. Americas Spinal Muscular Atrophy Medicine Revenue 2017-2022 ($ Millions)

Figure 33. APAC Spinal Muscular Atrophy Medicine Sales 2017-2022 (K Pcs)

Figure 34. APAC Spinal Muscular Atrophy Medicine Revenue 2017-2022 ($ Millions)

Figure 35. Europe Spinal Muscular Atrophy Medicine Sales 2017-2022 (K Pcs)

Figure 36. Europe Spinal Muscular Atrophy Medicine Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Spinal Muscular Atrophy Medicine Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Spinal Muscular Atrophy Medicine Revenue 2017-2022 ($ Millions)

Figure 39. Americas Spinal Muscular Atrophy Medicine Sales Market Share by Country in 2021

Figure 40. Americas Spinal Muscular Atrophy Medicine Revenue Market Share by Country in 2021

Figure 41. United States Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Spinal Muscular Atrophy Medicine Sales Market Share by Region in 2021

Figure 46. APAC Spinal Muscular Atrophy Medicine Revenue Market Share by Regions in 2021

Figure 47. China Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Country in 2021

Figure 54. Europe Spinal Muscular Atrophy Medicine Revenue Market Share by Country in 2021

Figure 55. Germany Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Spinal Muscular Atrophy Medicine Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Spinal Muscular Atrophy Medicine Revenue Market Share by Country in 2021

Figure 62. Egypt Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Spinal Muscular Atrophy Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Spinal Muscular Atrophy Medicine in 2021

Figure 68. Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine

Figure 69. Industry Chain Structure of Spinal Muscular Atrophy Medicine

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles